Results 261 to 270 of about 995,312 (298)

Behavioral stimulation of ovarian growth

Hormones and Behavior, 1988
The present study was conducted to test the following hypothesis: male courtship induced egg-laying behavior in the female ring dove is mediated by the female's nest-coo display which feeds back to stimulate her ovarian system through the mechanisms of audio- and proprioceptive feedback. In Experiment I, females were exposed to 24 hr male courtship and
M F, Cheng, C, Desiderio, M, Havens, A, Johnson   +3 more
openaire   +2 more sources

Ovarian stimulation and embryo quality

Reproductive BioMedicine Online, 2009
To study the effects of different ovarian stimulation approaches on oocyte and embryo quality, it is imperative to assess embryo quality with a reliable and objective method. Embryos rated as high quality by standardized morphological assessment are associated with higher implantation and pregnancy rates.
Baart, Esther, Macklon, N.S., Fauser, B.J.C.M.   +2 more
openaire   +3 more sources

Ovarian stimulation for in-vitro fertilization

Human Reproduction, 1988
In-vitro fertilization (IVF) and embryo transfer has become an accepted clinical method for the treatment of sterility. Different types of ovarian stimulation have been used successfully. The therapeutic principles behind the stimulation treatment in an IVF programme are the same as those applied in the treatment of normal and hypogonadotrophic ovarian
K, Diedrich, H, van der Ven, S, Al-Hasani, D, Krebs   +3 more
openaire   +2 more sources

Renewing ovarian stimulation

Reproductive BioMedicine Online
Conventional ovarian stimulation protocols were designed for fresh embryo transfer. They start in the early follicular phase, i.e. the infamous day 2-3, gonadotrophin-releasing hormone analogues are used to prevent premature ovulation, and the stimulation is harnessed due to the fear of ovarian hyperstimulation syndrome and the decreasing chance of a ...
openaire   +2 more sources

Ovarian stimulation in cancer patients

Fertility and Sterility, 2013
The patients referred for fertility preservation owing to a malignant disease do not represent the typical population of subfertile patients treated in IVF units. Cancer may affect multiple tissues throughout the body and can result in a variety of complications during controlled ovarian stimulation.
Hakan, Cakmak, Mitchell P, Rosen
openaire   +2 more sources

Developments in drugs for ovarian stimulation

Best Practice & Research Clinical Obstetrics & Gynaecology, 2003
Drugs for ovarian stimulation have been improved during the last decades. Initially gonadotrophins were extracted from human pituitary glands and urine; nowadays they are produced from transformed cell-lines. All three gonadotrophins--follicle stimulating hormone (FSH), luteinizing hormone (LH) and human chorionic gonadotrophin (hCG)--are now marketed ...
M, Ludwig, L G, Westergaard, K, Diedrich, C Yding, Andersen   +3 more
openaire   +2 more sources

Progestin-primed ovarian stimulation

Current Opinion in Obstetrics & Gynecology
Purpose of review The use of progestins as pituitary suppressors has increased progressively, along with more detailed indications for their use, thereby consolidating an alternative approach to the personalization of ovarian stimulation.
Giles, J, Cruz, F, Garcia-Velasco, JA
openaire   +3 more sources

Ovarian Stimulation and Granulosa-Cell Tumour

Obstetrical & Gynecological Survey, 1993
Ovarian stimulation in the treatment of infertility is far from physiological because patients and their ovaries are exposed to high concentrations of gonadotropins. Many studies have focused on the two most common side-effects of ovarian stimulation--ie, hyperstimulation and multiple pregnancy. We describe 12 patients in whom granulosa-cell tumour was
W, Willemsen, R, Kruitwagen, B, Bastiaans, T, Hanselaar, R, Rolland   +4 more
openaire   +2 more sources

Ovarian stimulation for assisted reproduction

Current Opinion in Obstetrics and Gynecology, 1996
Regimens for ovarian stimulation that result in increased circulating follicle-stimulating hormone with low levels of luteinizing hormone produce adequate follicular growth and improved oocyte quality and cycle outcome. Recombinant follicle-stimulating hormone for subcutaneous use and antagonists of gonadotropin-releasing hormone promise to simplify ...
openaire   +2 more sources

Aromatase inhibitors in ovarian stimulation

The Journal of Steroid Biochemistry and Molecular Biology, 2007
The selective estrogen receptor modulator, clomiphene citrate (CC), has been the principal drug used for induction of ovulation in women with polycystic ovarian syndrome (PCOS). CC is associated with adverse side effects and low pregnancy rates attributed to long-lasting estrogen receptor depletion.
openaire   +2 more sources